SMS Lifesciences India Limited

NSE SMSLIFE.NS

SMS Lifesciences India Limited Price to Earnings Ratio (P/E) on February 06, 2025: 40.20

SMS Lifesciences India Limited Price to Earnings Ratio (P/E) is 40.20 on February 06, 2025, a 171.02% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

SMS Lifesciences India Limited 52-week high Price to Earnings Ratio (P/E) is 57.81 on September 09, 2024, which is 43.80% above the current Price to Earnings Ratio (P/E).
SMS Lifesciences India Limited 52-week low Price to Earnings Ratio (P/E) is 14.51 on February 15, 2024, which is -63.90% below the current Price to Earnings Ratio (P/E).
SMS Lifesciences India Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 33.26.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NSE: SMSLIFE.NS

SMS Lifesciences India Limited

CEO	Mr. Talluri Veera Venkata Satyanarayana Murthy
IPO Date	Aug. 18, 2017
Location	India
Headquarters	Plot No. 19-III
Employees	574
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care Plastics

Description

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.

Key trends

Past 5 years